BioGemex

NEWS & EVENTS

NEWS & EVENTS

Subject

BIOGEMEX-XYLONIX cosponsored MoA study started at A*Star, Singapore

Name BioGemex
Date 19-10-31 11:25
View 356회

Contents

BIOGEMEX-XYLONIX cosponsored MoA study started at A*Star, Singapore

-        - Animal study for the diagnostic mechanism for PKA and XDX-01 started, co-sponsored by BioGemex and Xylonix  

-        - The study design and management are by Xylonix, and it is being performed at an A*Star affiliated CRO.     

-        - The study will prepare for regulatory documentations and patent expansions.


SEOUL/SINGAPORE, 16 October 2019, BioGemex (BioGemex.com) and Xylonix (Xylonix.io) today announced the start of the mode-of-mechanism animal study for corroborating PKA and XDX-01 at an A*Star affiliated CRO, Invivocue Ltd.

A clear scientific rationale is increasingly becoming important in patenting and regulatory considerations, and this study designed for meeting the need for both PKA and XDX-01. The study will be the first test of the aggregation-free PKA testing ELISA platform developed by BioGemex.

Accordingly, BioGemex and Xylonix executed a data access license between the two companies for enabling the co-investigation.

The companies expect the result of the test to be used in additional patent filing in 2020Q1.

Ends

Media enquiries

BioGemex

Email: media@biogemex.com

Tel: +82 70 5096 8929

 

Business

#3, 620, Samseong-ro, Gangnam-gu, Seoul,06085, Korea

TEL : +82-70-5096-5936

FAX : +82-2-569-7644

EMAIL : business@biogemex.com

R&D

#317, Hyundai I-Valley, 31, Galmachi-ro 244beon-gil, Jungwon-gu, Seongnam-si, Gyeonggi-do, 13212, Korea

TEL: +82-70-7753-2260

FAX : +82-31-737-9806

EMAIL: rnd@biogemex.com

Manufacture

#318, Hyundai I-Valley, 31, Galmachi-ro 244beon-gil, Jungwon-gu, Seongnam-si, Gyeonggi-do, 13212, Korea

TEL : +82-31-737-9800

FAX : +82-31-737-9806

EMAIL : manufacture@biogemex.com